Go to deals
Private Equity | Healthcare

AmberStone Group has acquired a stake in Vītola Klīnika and has developed New Hanza Med in Riga

AmberStone Group AS has acquired a 49% stake in Vītola Klīnika and invested in its expansion and relocation to new premises, leading to the creation of New Hanza Med — a modern, multidisciplinary medical and surgical center in the New Hanza district of Riga, Latvia.

Located at Mihaila Tāla iela 1, the new facility brings together specialists from diverse healthcare fields under one roof, providing a full spectrum of services from preventive care to complex surgical procedures. With this project, the group continues to strengthen its position in the healthcare sector, aiming to bring world-class medical standards to Latvia.

AmberStone Group is a Latvia-based investment holding company founded in 2013, specializing in private equity-style investments across sectors including healthcare, hospitality, agriculture, construction, wood processing and renewable energy. The group has extensive experience and a strong track record in developing medical facilities, notably ORTO Clinic.

Vītola Klīnika offers a comprehensive range of gynecological, diagnostic and surgical services delivered by experienced specialists. Patients benefit from advanced technology, effective treatment methods and a personalized approach, ensuring a seamless continuum of care from initial consultation and diagnostics through surgery and post-operative recovery.

Oaklins’ team in Latvia acted as the exclusive buy-side advisor to AmberStone Group, supporting the investment thesis, identifying potential acquisition targets, facilitating introductions and negotiating deal terms.

Parties

Talk to the deal team

Evelīna Valtere

Associate Director
Riga, Latvia
Oaklins Baltics

Related deals

Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more